Heroin addiction in African Americans: a hypothesis-driven association study.
paper
Cited
Public
- Authors
- Levran, O; Londono, D; O'Hara, K; Randesi, M; Rotrosen, J; Casadonte, P; Linzy, S; Ott, J; Adelson, M; Kreek, M J
- Year
- 2009
- Journal
- Genes, brain, and behavior
- PMID
- 19500151
- DOI
- 10.1111/j.1601-183X.2009.00501.x
- PMCID
- PMC2716061
Heroin addiction is a chronic complex disease with a substantial genetic contribution. This study was designed to identify gene variants associated with heroin addiction in African Americans. The emphasis was on genes involved in reward modulation, behavioral control, cognitive function, signal transduction and stress response. We have performed a case-control association analysis by screening with 1350 variants of 130 genes. The sample consisted of 202 former severe heroin addicts in methadone treatment and 167 healthy controls with no history of drug abuse. Single nucleotide polymorphism (SNP), haplotype and multi-SNP genotype pattern analyses were performed. Seventeen SNPs showed point-wise significant association with heroin addiction (nominal P< 0.01). These SNPs are from genes encoding several receptors: adrenergic (ADRA1A), arginine vasopressin (AVPR1A), cholinergic (CHRM2), dopamine (DRD1), GABA-A (GABRB3), glutamate (GRIN2A) and serotonin (HTR3A) as well as alcohol dehydrogenase (ADH7), glutamic acid decarboxylase (GAD1 and GAD2), the nucleoside transporter (SLC29A1) and diazepam-binding inhibitor (DBI). The most significant result of the analyses was obtained for the GRIN2A haplotype G-A-T (rs4587976-rs1071502-rs1366076) with protective effect (P(uncorrected) = 9.6E- 05, P(corrected) = 0.058). This study corroborates several reported associations with alcohol and drug addiction as well as other related disorders and extends the list of variants that may affect the development of heroin addiction. Further studies will be necessary to replicate these associations and to elucidate the roles of these variants in drug addiction vulnerability.
No figures extracted from this document.
β Prev
21β34 of 34
No entities extracted from this document yet.
No uploaded files.
Not in any collection.
In this knowledge base
External
| Title | Authors | Journal | Year | Link |
|---|---|---|---|---|
| Association Between the (GT)26 Allele in the GRIN2A Promoter and Opioid Use Disorder. | Xie X et al. | β | 2025 | β |
| Biochemical Diagnosis in Substance and Non-substance Addiction. | Shen W et al. | β | 2025 | β |
| Genetic and Epigenetic Approaches to Opioid Use Disorder. | Ranadeva ND et al. | β | 2025 | β |
| Genomic landscape of the Great Steppe: Genetic variants in healthy Kazakh individuals. | Serikzhan A et al. | β | 2025 | β |
| Targeting and Modulation of Oxidative Stress Biomarkers by NDRI Therapy in Heroin- Dependent Patients: Insights from a case-control study in Pakistan | Rashid S et al. | β | 2025 | β |
| Aberrant glutamatergic systems underlying impulsive behaviors: Insights from clinical and preclinical research. | Yates JR | β | 2024 | β |
| SNP analysis of stress-related genes reveals significant correlations with drug addiction in Jordan. | Al-Eitan L et al. | β | 2024 | β |
| An alcohol dehydrogenase 7 gene polymorphism associates with both acute and chronic pain in sickle cell disease. | Kashyap Y et al. | β | 2023 | β |
| Invited Expert Opinion- Bioinformatic and Limitation Directives to Help Adopt Genetic Addiction Risk Screening and Identify Preaddictive Reward Dysregulation: Required Analytic Evidence to Induce Dopamine Homeostatsis. | Blum K et al. | β | 2023 | β |
| Analyses of polymorphisms of intron 2 of OPRK1 (kappa-opioid receptor gene) in association with opioid and cocaine dependence diagnoses in an African-American population. | Yuferov V et al. | β | 2022 | β |
| Age of onset of heaviest use of cannabis or alcohol in persons with severe opioid or cocaine use disorders. | Butelman ER et al. | β | 2021 | β |
| Association study of genetic polymorphisms in <i>GABRD</i> with treatment response and dose in methadone maintenance treatment. | Xie X et al. | β | 2021 | β |
| A systems omics-based approach to decode substance use disorders and neuroadaptations. | Veerappa A et al. | β | 2021 | β |
| OPRD1 SNPs associated with opioid addiction are cis-eQTLs for the phosphatase and actin regulator 4 gene, PHACTR4, a mediator of cytoskeletal dynamics. | Levran O et al. | β | 2021 | β |
| The escalation in ethanol consumption following chronic intermittent ethanol exposure is blunted in mice expressing ethanol-resistant GluN1 or GluN2A NMDA receptor subunits. | Zamudio PA et al. | β | 2021 | β |
| Neuropharmacological and Neurogenetic Correlates of Opioid Use Disorder (OUD) As a Function of Ethnicity: Relevance to Precision Addiction Medicine. | Abijo T et al. | β | 2020 | β |
| Pharmacogenetics of drug dependence: Polymorphisms of genes involved in glutamate neurotransmission. | Nudmamud-Thanoi S et al. | β | 2020 | β |
| The Streetlight Effect: Reappraising the Study of Addiction in Light of the Findings of Genome-wide Association Studies. | Hall FS et al. | β | 2020 | β |
| Bi-directional Acceleration of Alcohol Use and Opioid Use Disorder. | Huang W et al. | β | 2019 | β |
| Molecular Imaging of Opioid and Dopamine Systems: Insights Into the Pharmacogenetics of Opioid Use Disorders. | Burns JA et al. | β | 2019 | β |
| VMAT2 gene (<i>SLC18A2</i>) variants associated with a greater risk for developing opioid dependence. | Randesi M et al. | β | 2019 | β |
| A non-coding CRHR2 SNP rs255105, a cis-eQTL for a downstream lincRNA AC005154.6, is associated with heroin addiction. | Levran O et al. | β | 2018 | β |
| Chronic Oxycodone Self-administration Altered Reward-related Genes in the Ventral and Dorsal Striatum of C57BL/6J Mice: An RNA-seq Analysis. | Zhang Y et al. | β | 2018 | β |
| Emotion recognition associated with polymorphism in oxytocinergic pathway gene ARNT2. | Hovey D et al. | β | 2018 | β |
| Implication of Genes for the N-Methyl-D-Aspartate (NMDA) Receptor in Substance Addictions. | Chen J et al. | β | 2018 | β |
| Association of OPRD1 Gene Variants with Opioid Dependence in Addicted Male Individuals Undergoing Methadone Treatment in the North of Iran. | Sharafshah A et al. | β | 2017 | β |
| Biochemical Diagnosis in Substance and Non-substance Addiction. | Shen W et al. | β | 2017 | β |
| The Human Serotonin Type 3 Receptor Gene (HTR3A-E) Allelic Variant Database. | Celli J et al. | β | 2017 | β |
| African-specific variability in the acetylcholine muscarinic receptor M4: association with cocaine and heroin addiction. | Levran O et al. | β | 2016 | β |
| Glutamatergic and GABAergic susceptibility loci for heroin and cocaine addiction in subjects of African and European ancestry. | Levran O et al. | β | 2016 | β |
| ENT1 inhibition attenuates epileptic seizure severity via regulation of glutamatergic neurotransmission. | Xu Z et al. | β | 2015 | β |
| GABRB2 Haplotype Association with Heroin Dependence in Chinese Population. | Kim YS et al. | β | 2015 | β |
| Overlapping dopaminergic pathway genetic susceptibility to heroin and cocaine addictions in African Americans. | Levran O et al. | β | 2015 | β |
| Repeated ketamine administration alters N-methyl-D-aspartic acid receptor subunit gene expression: implication of genetic vulnerability for ketamine abuse and ketamine psychosis in humans. | Xu K et al. | β | 2015 | β |
| Susceptibility loci for heroin and cocaine addiction in the serotonergic and adrenergic pathways in populations of different ancestry. | Levran O et al. | β | 2015 | β |
| Synaptic Plasticity and Signal Transduction Gene Polymorphisms and Vulnerability to Drug Addictions in Populations of European or African Ancestry. | Levran O et al. | β | 2015 | β |
| The GAD65 knock out mouse - a model for GABAergic processes in fear- and stress-induced psychopathology. | MΓΌller I et al. | β | 2015 | β |
| The role of serotonin in drug use and addiction. | MΓΌller CP et al. | β | 2015 | β |
| An enhancer-blocking element regulates the cell-specific expression of alcohol dehydrogenase 7. | Jairam S et al. | β | 2014 | β |
| Association analysis of GABRB3 promoter variants with heroin dependence. | Chen CH et al. | β | 2014 | β |
| Association and interaction analyses of 5-HT3 receptor and serotonin transporter genes with alcohol, cocaine, and nicotine dependence using the SAGE data. | Yang J et al. | β | 2014 | β |
| Dopaminergic pathway polymorphisms and heroin addiction: further support for association of CSNK1E variants. | Levran O et al. | β | 2014 | β |
| Drug addiction and stress-response genetic variability: association study in African Americans. | Levran O et al. | β | 2014 | β |
| Extended access oxycodone self-administration and neurotransmitter receptor gene expression in the dorsal striatum of adult C57BL/6Β J mice. | Zhang Y et al. | β | 2014 | β |
| Genetics of opiate addiction. | Reed B et al. | β | 2014 | β |
| Pharmacogenetics of OPRM1. | Crist RC et al. | β | 2014 | β |
| Single-nucleotide polymorphisms interact to affect ADH7 transcription. | Jairam S et al. | β | 2014 | β |
| Stress-related genes and heroin addiction: a role for a functional FKBP5 haplotype. | Levran O et al. | β | 2014 | β |
| Advances in genetic studies of substance abuse in China. | Sun Y et al. | β | 2013 | β |
| Analysis of variations in the glutamate receptor, N-methyl D-aspartate 2A (GRIN2A) gene reveals their relative importance as genetic susceptibility factors for heroin addiction. | Zhao B et al. | β | 2013 | β |
| Association of genetic variation in pharmacodynamic factors with methadone dose required for effective treatment of opioid addiction. | Levran O et al. | β | 2013 | β |
| Dopamine receptor D1 and postsynaptic density gene variants associate with opiate abuse and striatal expression levels. | Jacobs MM et al. | β | 2013 | β |
| Retinoid metabolism is altered in human and mouse cicatricial alopecia. | Everts HB et al. | β | 2013 | β |
| The dopamine receptor D1 gene is associated with the length of interval between first heroin use and onset of dependence in Chinese Han heroin addicts. | Peng S et al. | β | 2013 | β |
| A C17T polymorphism in the mu opiate receptor is associated with quantitative measures of drug use in African American women. | Crystal HA et al. | β | 2012 | β |
| Association between a polymorphism in the promoter of a glutamate receptor subunit gene (GRIN2A) and alcoholism. | Domart MC et al. | β | 2012 | β |
| Common and specific liability to addiction: approaches to association studies of opioid addiction. | Nielsen DA et al. | β | 2012 | β |
| Custom genotyping for substance addiction susceptibility genes in Jordanians of Arab descent. | Al-Eitan LN et al. | β | 2012 | β |
| Estimating ancestral proportions in a multi-ethnic US sample: implications for studies of admixed populations. | Levran O et al. | β | 2012 | β |
| Genetic association analyses of PDYN polymorphisms with heroin and cocaine addiction. | Clarke TK et al. | β | 2012 | β |
| Genetics of dopamine receptors and drug addiction. | Gorwood P et al. | β | 2012 | β |
| Genome-wide association study of comorbid depressive syndrome and alcohol dependence. | Edwards AC et al. | β | 2012 | β |
| Nerve growth factor Ξ² polypeptide (NGFB) genetic variability: association with the methadone dose required for effective maintenance treatment. | Levran O et al. | β | 2012 | β |
| The 5-HT3B subunit affects high-potency inhibition of 5-HT3 receptors by morphine. | Baptista-Hon DT et al. | β | 2012 | β |
| The aggregate effect of dopamine genes on dependence symptoms among cocaine users: cross-validation of a candidate system scoring approach. | Derringer J et al. | β | 2012 | β |
| The genetics of the opioid system and specific drug addictions. | Levran O et al. | β | 2012 | β |
| Functional role of the polymorphic 647 T/C variant of ENT1 (SLC29A1) and its association with alcohol withdrawal seizures. | Kim JH et al. | β | 2011 | β |
| Functions of arginine vasopressin and its receptors: importance of human molecular genetics studies in bidirectional translational research. | Kreek MJ et al. | β | 2011 | β |
| Genome-wide gene-environment study identifies glutamate receptor gene GRIN2A as a Parkinson's disease modifier gene via interaction with coffee. | Hamza TH et al. | β | 2011 | β |
| Haplotype block structure of the genomic region of the mu opioid receptor gene. | Levran O et al. | β | 2011 | β |
| Type 1 equilibrative nucleoside transporter regulates ethanol drinking through accumbal N-methyl-D-aspartate receptor signaling. | Nam HW et al. | β | 2011 | β |
| 5-HT(3) receptors: role in disease and target of drugs. | Walstab J et al. | β | 2010 | β |
| An essential role for adenosine signaling in alcohol abuse. | Ruby CL et al. | β | 2010 | β |
| Drug-induced and genetic alterations in stress-responsive systems: Implications for specific addictive diseases. | Zhou Y et al. | β | 2010 | β |
| Ethnic diversity of DNA methylation in the OPRM1 promoter region in lymphocytes of heroin addicts. | Nielsen DA et al. | β | 2010 | β |